I. Sari Et Al. , "Ga-67 Uptake: a Predictor of Post-Therapy Active Residual Disease and Clinical Outcome in Patients with Diffuse Large Cell Lymphoma," ERCIYES MEDICAL JOURNAL , vol.30, no.1, pp.8-13, 2008
Sari, I. Et Al. 2008. Ga-67 Uptake: a Predictor of Post-Therapy Active Residual Disease and Clinical Outcome in Patients with Diffuse Large Cell Lymphoma. ERCIYES MEDICAL JOURNAL , vol.30, no.1 , 8-13.
Sari, I., Kula, M., Eser, B., KAYNAR, L., ALTUNTAŞ, F., KOÇYİĞİT, İ., ... Mavili, E.(2008). Ga-67 Uptake: a Predictor of Post-Therapy Active Residual Disease and Clinical Outcome in Patients with Diffuse Large Cell Lymphoma. ERCIYES MEDICAL JOURNAL , vol.30, no.1, 8-13.
Sari, Ismail Et Al. "Ga-67 Uptake: a Predictor of Post-Therapy Active Residual Disease and Clinical Outcome in Patients with Diffuse Large Cell Lymphoma," ERCIYES MEDICAL JOURNAL , vol.30, no.1, 8-13, 2008
Sari, Ismail Et Al. "Ga-67 Uptake: a Predictor of Post-Therapy Active Residual Disease and Clinical Outcome in Patients with Diffuse Large Cell Lymphoma." ERCIYES MEDICAL JOURNAL , vol.30, no.1, pp.8-13, 2008
Sari, I. Et Al. (2008) . "Ga-67 Uptake: a Predictor of Post-Therapy Active Residual Disease and Clinical Outcome in Patients with Diffuse Large Cell Lymphoma." ERCIYES MEDICAL JOURNAL , vol.30, no.1, pp.8-13.
@article{article, author={Ismail Sari Et Al. }, title={Ga-67 Uptake: a Predictor of Post-Therapy Active Residual Disease and Clinical Outcome in Patients with Diffuse Large Cell Lymphoma}, journal={ERCIYES MEDICAL JOURNAL}, year=2008, pages={8-13} }